Help protect your patients from the risks of pharmacy manufacturing

Help protect your patients from the risks of pharmacy manufacturing

To ensure that your patients receive the proper medication, follow these simple suggestions:

  • Check Dispense as Written (DAW) or write Do Not Substitute on all prescriptions
  • Review all prescription faxes prior to authorizing them with your signature
  • Question all pharmacy-generated changes to prescriptions that specify the brand name
  • Dispute any claims that pharmacists can provide you with an equivalent drug. Remember, compounded budesonide is not the same as PULMICORT RESPULES
  • Check patients’ medications during follow–up visits
  • Ask patients or caregivers to inform you if they do not receive PULMICORT RESPULES as prescribed
  • Report incidents of unauthorized substitution of compounded budesonide for PULMICORT RESPULES to your State Board of Pharmacy or FDA

NEXT: Additional resources

Indication and Important Safety Information

PULMICORT RESPULES is indicated for the maintenance treatment of asthma and as prophylactic therapy in children ages 12 months to 8 years.

PULMICORT RESPULES is not a bronchodilator and is NOT indicated for the relief of acute bronchospasm.

The most common adverse events reported in clinical trials, regardless of relationship to treatment, include respiratory infection, rhinitis, coughing, and otitis media.

Inhaled corticosteroids may cause a reduction in growth velocity. The long-term effect on final adult height is unknown.

PULMICORT RESPULES, like other inhaled corticosteroids, may impact the hypothalamic-pituitary-adrenal axis, especially in susceptible individuals, in young children, and in patients given high doses for prolonged periods.

Adrenal insufficiency may occur when transferring patients from systematic corticosteroids (see WARNING in full Prescribing Information).

Patients taking immunosuppressant doses of corticosteroids should avoid exposure to infections such as chicken pox and measles.

Please see accompanying full Prescribing Information.